HTR2B expression levels are elevated within VAT in people with obesity, and selective HTR2B antagonists may attenuate the inflammatory response in VAT and obesity-associated IR [195]. The gene discussed is HTR2B; the disease is obesity due to melanocortin 4 receptor deficiency.